Biovica International AB (OSTO:BIOVIC B) Long-Term Capital Lease Obligation : kr4.80 Mil (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Long-Term Capital Lease Obligation?

Biovica International AB's Long-Term Capital Lease Obligation for the quarter that ended in Jan. 2024 was kr4.80 Mil.

Biovica International AB's quarterly Long-Term Capital Lease Obligation declined from Jul. 2023 (kr6.63 Mil) to Oct. 2023 (kr5.84 Mil) and declined from Oct. 2023 (kr5.84 Mil) to Jan. 2024 (kr4.80 Mil).

Biovica International AB's annual Long-Term Capital Lease Obligation increased from Apr. 2021 (kr0.93 Mil) to Apr. 2022 (kr8.78 Mil) but then declined from Apr. 2022 (kr8.78 Mil) to Apr. 2023 (kr7.30 Mil).

Biovica International AB Long-Term Capital Lease Obligation Historical Data

The historical data trend for Biovica International AB's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Long-Term Capital Lease Obligation Chart

Biovica International AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.27

0.93

8.78

7.30

Biovica International AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															7.99	7.30	6.63	5.84	4.80

Biovica International AB (OSTO:BIOVIC B) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Biovica International AB Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB (OSTO:BIOVIC B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

9II:Germany

Address

Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37

Website

http://www.biovica.com

Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines